THYROID GLAND SQUAMOUS CELL CARCINOMA
Clinical trials for THYROID GLAND SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID GLAND SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID GLAND SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fighting tough cancers with a Patient's own supercharged immune cells
Disease control OngoingThis study is testing a personalized cell therapy called LN-145 for patients with advanced cancers that have stopped responding to standard treatments. Doctors collect a patient's own immune cells from their tumor, grow large numbers of them in a lab, and then infuse them back in…
Matched conditions: THYROID GLAND SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 04:18 UTC
-
New drug duo aims to tame aggressive thyroid cancer
Disease control OngoingThis study is testing whether two drugs, lenvatinib and pembrolizumab, work better together for people with advanced anaplastic thyroid cancer that cannot be removed by surgery or has spread. Lenvatinib aims to block tumor growth, while pembrolizumab helps the body's immune syste…
Matched conditions: THYROID GLAND SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Three-Pronged attack tested to tame deadly thyroid cancer before surgery
Disease control OngoingThis study is testing a combination of three drugs given before surgery for patients with a very aggressive type of thyroid cancer that has a specific genetic change (BRAF V600E mutation). The goal is to shrink the tumor and make it easier to remove completely during surgery, whi…
Matched conditions: THYROID GLAND SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug aims to shrink tough thyroid tumors before surgeons operate
Disease control OngoingThis study is testing whether a targeted pill called selpercatinib can shrink thyroid tumors before surgery. It is for people with advanced thyroid cancer that has a specific genetic change (RET alteration). The goal is to see if shrinking the tumor first makes surgery easier and…
Matched conditions: THYROID GLAND SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC